KRAS and non-small cell lung carcinoma: This uncertainty is probably related to the co-occurrence of alterations other than those involving PI3K; a genomic sequencing of specimens from early-stage NSCLC revealed PIK3CA as the most frequently mutated gene in co-existence with EGFR and KRAS mutations [89].